We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

175 hedge funds and large institutions have $706M invested in DIPLOMAT PHARMACY, INC. in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 12

103% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 37

32% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $1.44M

13% more funds holding

Funds holding: 155175 (+20)

9% less capital invested

Capital invested by funds: $778M → $706M (-$71.2M)

Holders
175
Holders Change
+20
Holders Change %
+12.9%
% of All Funds
4.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
75
Reduced
37
Closed
12
Calls
$1.89M
Puts
$1.44M
Net Calls
+$453K
Net Calls Change
+$539K
Name Holding Trade Value Shares
Change
Change in
Stake
DTL
76
Dynamic Technology Lab
Singapore
$610K +$687K +41,233 New
NIT
77
NumerixS Investment Technologies
British Columbia, Canada
$604K +$542K +32,500 +392%
State of Tennessee, Department of Treasury
78
State of Tennessee, Department of Treasury
Tennessee
$597K
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$557K +$20.2K +1,211 +3%
New York State Teachers Retirement System (NYSTRS)
80
New York State Teachers Retirement System (NYSTRS)
New York
$549K
ECM
81
Endurant Capital Management
California
$522K -$830K -49,800 -59%
AIG
82
American International Group
New York
$522K +$118K +7,089 +25%
RJA
83
Raymond James & Associates
Florida
$521K -$36.2K -2,171 -6%
Royal Bank of Canada
84
Royal Bank of Canada
Ontario, Canada
$521K +$118K +7,056 +25%
CSS
85
Cubist Systematic Strategies
Connecticut
$518K +$583K +34,987 New
FA
86
FCG Advisors
New Jersey
$503K +$567K +34,000 New
Renaissance Technologies
87
Renaissance Technologies
New York
$490K +$86.7K +5,200 +19%
CA
88
Continental Advisors
Utah
$485K +$547K +32,800 New
ERSOT
89
Employees Retirement System of Texas
Texas
$474K -$300K -18,000 -36%
MLICM
90
Metropolitan Life Insurance Company (MetLife)
New York
$474K
TPSF
91
Texas Permanent School Fund
Texas
$472K +$7.83K +470 +1%
PA
92
Perceptive Advisors
New York
$454K +$511K +30,658 New
WMSA
93
Weiss Multi-Strategy Advisers
New York
$444K +$333K +20,000 +200%
QT
94
Quantbot Technologies
New York
$429K +$484K +29,028 New
OAM
95
Oppenheimer Asset Management
New York
$400K -$8.43K -506 -2%
Thrivent Financial for Lutherans
96
Thrivent Financial for Lutherans
Minnesota
$389K -$4.74M -284,310 -92%
CS
97
Credit Suisse
Switzerland
$369K -$430K -25,827 -51%
CAM
98
Capstone Asset Management
Texas
$362K +$2K +120 +0.5%
FA
99
FDx Advisors
Illinois
$357K +$50.5K +3,033 +14%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$354K

DPLO Hedge Fund Activity: Q2 2017 in Review

175 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2017, worth a combined $706M — down 9.2% from $778M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new DPLO positions and 12 closed out — a net gain of 21 holders — while 75 added to existing stakes and 37 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $76M. The largest seller was T. Rowe Price Associates, cutting an estimated $21M.

  • 175 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2017, up from 155 in Q1 2017.
  • Funds reported $706M of DIPLOMAT PHARMACY, INC. stock for Q2 2017, down 9.2% quarter-over-quarter.
  • 33 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2017 and 12 closed out, a net change of +21 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2017 was Janus Henderson Group, an estimated $76M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q2 2017 was T. Rowe Price Associates, an estimated $21M sold.

Based on aggregated 13F filings for Q2 2017.